Bioactive Compounds
-
BA1879 HCV-IN-30Summary: HCV-IN-30 is a hepatitis C virus replication complex inhibitor. - BA1878 HCV-IN-31Summary: HCV-IN-31 is an inhibitor.
- BA1877 Nucleoside-Analog-2Summary: Nucleoside-Analog-2 is a 4'-azacytidine analog that targets hepatitis C virus replication.
- BA1876 IDX184Summary: IDX184 is a potent, orally active replication inhibitor.
- BA1875 PSI-6130Summary: PSI-6130 is highly efficient and selective inhibitor.
- BA1874 FilibuvirSummary: Filibuvir is an orally effective, selective non-nucleoside inhibitor of the non-structural 5B protein RNA-dependent RNA polymerase (RdRp).
- BA1873 MiravirsenSummary: Miravirsen (SPC-3649) is a potent inhibitor of miR-122 biogenesis.
- BA1872 UprifosbuvirSummary: Uprifosbuvir is an antiviral active molecule.
- BA1871 PF-4878691Summary: PF-4878691 (3M-852A) is an orally active agonist.
- BA1870 ABT-072Summary: ABT-072 is a potent non-nucleoside inhibitor with oral activity.